A carregar...
Treating primary-progressive multiple sclerosis: potential of ocrelizumab and review of B-cell therapies
Multiple sclerosis (MS) therapy has evolved rapidly with an increased availability of several immunomodulating therapies over the past two decades. Disease-modifying therapies have proven to be effective in treating relapse–remitting MS (RRMS). However, clinical trials involving some of the same age...
Na minha lista:
| Publicado no: | Degener Neurol Neuromuscul Dis |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6053100/ https://ncbi.nlm.nih.gov/pubmed/30050376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DNND.S100096 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|